Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent, selective and orally bioavailable FTase inhibitor presented by Abbott

Aug. 20, 2002

Iressa NSCLC trial results show no improvement in combined treatment with standard chemotherapy

Aug. 20, 2002

Salicylate protects against the ototoxic and nephrotoxic side effects of cisplatin in rats

Aug. 20, 2002

Phase I solid tumor trial initiated for KSP inhibitor

Aug. 20, 2002

ARC enters research agreement with McGill University for antisense oligonucleotide therapeutics

Aug. 20, 2002

Interferon inducers described by Sumitomo and Japan Energy at ACS meeting

Aug. 19, 2002

Enrollment initiated in phase III atamestane trial

Aug. 19, 2002

Viragen and U. of Miami collaborate on immune enhancing drug for cancer

Aug. 19, 2002

Novel EGFR inhibitors in early development at Boehringer Ingelheim

Aug. 14, 2002

FDA approves Eloxatin for advanced colorectal cancer

Aug. 14, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...